Does Urenco's LEU+ Production Solve the SMR Fuel Supply Challenge?

Urenco has successfully produced LEU+ (5-10% Enrichment) at its Capenhurst facility in the UK during its first trial run, the company announced May 6. The demonstration produced uranium enriched between 5-10% U-235, filling a critical gap between conventional reactor fuel (3-5% enrichment) and High-Assay Low-Enriched Uranium (19.75% enrichment) needed for advanced reactors.

The trial run validates Urenco's existing gas centrifuge technology can produce intermediate enrichment levels without major infrastructure modifications. This positions the Anglo-Dutch-German consortium to serve emerging SMR markets that require LEU+ fuel, including several Generation III+ designs and some Generation IV concepts that don't require full HALEU enrichment levels.

The timing aligns with growing demand from SMR developers seeking fuel supply security. Unlike HALEU production, which requires specialized facilities and higher security protocols, LEU+ can be produced using modified conventional enrichment infrastructure. This could accelerate fuel availability for first-of-a-kind SMR deployments planned for the late 2020s.

Market Context for LEU+ Demand

The successful trial addresses a specific fuel supply gap that has emerged as SMR designs mature. While most attention focuses on HALEU shortages for advanced reactors, several near-term SMR deployments require LEU+ enrichment levels that fall between conventional and high-assay fuel.

NuScale Power's VOYGR design, for example, can operate on fuel enriched up to 4.95% U-235, just below the LEU+ threshold. However, optimization studies suggest higher enrichment levels could extend fuel cycles and improve economics. Similarly, Rolls-Royce SMR Ltd's pressurized water reactor design could benefit from LEU+ fuel for improved capacity factor and reduced refueling frequency.

The LEU+ category represents roughly 15-20% of projected SMR fuel demand through 2035, according to industry analysis. This creates a market opportunity worth approximately $500 million annually once commercial SMR deployment accelerates.

Urenco's demonstration comes as utilities increasingly focus on fuel supply chain resilience. The company operates enrichment facilities in the UK, Netherlands, Germany, and the US, providing geographic diversification that appeals to utilities concerned about supply disruptions.

Technical Implications and Production Scaling

The Capenhurst trial utilized Urenco's established gas centrifuge technology, suggesting minimal capital investment would be required for commercial LEU+ production. The facility currently produces conventional LEU for existing nuclear plants and could potentially allocate centrifuge capacity for higher enrichment levels based on market demand.

However, producing LEU+ at scale presents regulatory and operational challenges. Higher enrichment levels require enhanced material accounting and security measures, though less stringent than HALEU requirements. The UK's Office for Nuclear Regulation would need to approve modifications to Urenco's operating license for commercial LEU+ production.

Quality control becomes more critical at LEU+ enrichment levels. Small variations in U-235 concentration have larger impacts on reactor physics and fuel performance compared to conventional LEU. This requires tighter process control and more frequent analytical measurements during production.

Storage and transportation of LEU+ also requires consideration. While the material remains classified as low-enriched uranium for regulatory purposes, utilities may prefer specialized handling procedures to maintain fuel quality and prevent cross-contamination with conventional LEU inventories.

Competitive Landscape and Strategic Positioning

The successful trial strengthens Urenco's position in the evolving nuclear fuel market. Centrus Energy Corp currently dominates HALEU production discussions in the US market, but LEU+ represents a segment where established enrichers like Urenco can compete effectively.

Orano has also expressed interest in LEU+ production at its European facilities, setting up potential competition for SMR fuel contracts. The French company's tricastin enrichment plant could be modified for LEU+ production using similar centrifuge technology.

Russian enricher Rosatom historically supplied LEU+ for research reactors, but sanctions have created market opportunities for Western suppliers. Urenco's trial timing suggests the company aims to capture this displaced demand while positioning for future SMR requirements.

The demonstration also supports Urenco's partnership strategy with SMR developers. The company has signed fuel supply agreements with several SMR vendors, and LEU+ capability enhances its value proposition for designs requiring intermediate enrichment levels.

Regulatory and Market Development Timeline

Commercial LEU+ production at Capenhurst would require regulatory approval from UK authorities, a process typically taking 12-18 months for facility modifications. Urenco must demonstrate that LEU+ production won't impact existing commercial operations or compromise safety systems.

The company indicated additional trial runs would continue through 2026 to optimize production parameters and validate quality control procedures. This suggests commercial LEU+ availability by late 2027, aligning with early SMR construction schedules.

Market development for LEU+ depends partly on SMR licensing progress. NRC design certification approvals for SMR designs could specify fuel enrichment requirements, creating firm demand signals for enrichers like Urenco.

International markets present additional opportunities. Several countries developing SMR programs lack domestic enrichment capability, creating export potential for Urenco's LEU+ production once commercial operations begin.

Key Takeaways

• Urenco successfully demonstrated LEU+ production using existing centrifuge technology at Capenhurst
• LEU+ fills fuel supply gap between conventional reactor fuel and HALEU for advanced reactors
• Trial positions Urenco to serve emerging SMR market requiring intermediate enrichment levels
• Commercial production possible by 2027 following additional trials and regulatory approval
• LEU+ represents $500M annual market opportunity as SMR deployment accelerates
• Success strengthens Western fuel supply chain independence from Russian sources

Frequently Asked Questions

What is LEU+ and how does it differ from HALEU? LEU+ refers to uranium enriched to 5-10% U-235, compared to HALEU's 19.75% maximum. LEU+ serves SMR designs requiring higher enrichment than conventional reactors but less than advanced fast reactors needing HALEU.

Which SMR designs require LEU+ fuel? Several Generation III+ SMR designs can benefit from LEU+ fuel, including optimized versions of NuScale's VOYGR and Rolls-Royce SMR designs. The higher enrichment extends fuel cycles and improves reactor economics.

When will Urenco begin commercial LEU+ production? Following additional trials through 2026 and regulatory approval, Urenco could begin commercial LEU+ production at Capenhurst by late 2027, aligning with early SMR deployment schedules.

How large is the potential LEU+ market? Industry analysis suggests LEU+ represents 15-20% of projected SMR fuel demand through 2035, creating an annual market opportunity worth approximately $500 million once commercial deployment accelerates.

Can existing enrichment facilities produce LEU+? Yes, LEU+ can be produced using modified conventional gas centrifuge technology, requiring less infrastructure investment than HALEU production while still needing enhanced security and quality control measures.